,REPOSITORY ID,REPOSITORY LINK,SAMPLE NUMBER,STUDY TITLE,STUDY LINK,ASSAY TYPE,TECHNOLOGY,COUNTRY,DISEASE,DOID,STUDY DESIGN,BODY SITE,PLATFORM,PARTICIPANT FEATURES,AVERAGE SPOTLENGTH,RUN ID,Sample ID,Sample Name,COLLECTION DATE,LIBRARY LAYOUT,LAT LON,SAMPLE TYPE,ETHNICITY,ELO,URBANZATION,REGION,CITYVILLAGE,TARGET AMPLICON,DIET
0,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HCV,1883.0,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889523,SRS1560514,HCV_GM__AMA_P1_R1,02/22/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
1,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HCV,1883.0,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889524,SRS1560515,HCV_GM__AMA_P1_R2,02/22/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
2,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HCV,1883.0,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889525,SRS1560516,HCV_GM__AMA_P6_R1,02/22/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
3,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HCV,1883.0,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889526,SRS1560517,HCV_GM__AMA_P6_R2,02/22/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
4,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889527,SRS1560518,HEALTHY_GM_AMA_H1_R1,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
5,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889528,SRS1560519,HEALTHY_GM_AMA_H1_R2,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
6,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889529,SRS1560520,HEALTHY_GM_AMA_H2_R1,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
7,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889530,SRS1560521,HEALTHY_GM_AMA_H2_R2,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
8,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889531,SRS1560522,HEALTHY_GM_AMA_H3_R1,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
9,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889532,SRS1560523,HEALTHY_GM_AMA_H3_R2,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
10,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889533,SRS1560524,HEALTHY_GM_AMA_H4_R1,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
11,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889534,SRS1560525,HEALTHY_GM_AMA_H4_R2,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
12,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HCV,1883.0,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889535,SRS1560526,HCV_GM__AMA_P2_R1,02/22/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
13,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889536,SRS1560527,HEALTHY_GM_AMA_H5_R1,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
14,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889537,SRS1560528,HEALTHY_GM_AMA_H5_R2,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
15,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889538,SRS1560529,HEALTHY_GM_AMA_H6_R1,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
16,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889539,SRS1560532,HEALTHY_GM_AMA_H6_R2,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
17,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889540,SRS1560530,HEALTHY_GM_AMA_H7_R1,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
18,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889541,SRS1560531,HEALTHY_GM_AMA_H7_R2,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
19,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889542,SRS1560533,HEALTHY_GM_AMA_H8_R1,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
20,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HEALTHY,,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889543,SRS1560534,HEALTHY_GM_AMA_H8_R2,05/05/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
21,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HCV,1883.0,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889544,SRS1560535,HCV_GM__AMA_P2_R2,02/22/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
22,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HCV,1883.0,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889545,SRS1560536,HCV_GM__AMA_P3_R1,02/22/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
23,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HCV,1883.0,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889546,SRS1560537,HCV_GM__AMA_P3_R2,02/22/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
24,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HCV,1883.0,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889547,SRS1560538,HCV_GM__AMA_P4_R1,02/22/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
25,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HCV,1883.0,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889548,SRS1560539,HCV_GM__AMA_P4_R2,02/22/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
26,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HCV,1883.0,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889549,SRS1560540,HCV_GM__AMA_P5_R1,02/22/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
27,PRJNA328966,PRJNA328966,28.0,GUT MICROBIOME ALTERATIONS IN PATIENTS WITH STAGE 4 HEPATITIS C,27625705.0,AMPLICON,ILLUMINA,EGYPT,HCV,1883.0,CASE-CONTROL,GUT,ILLUMINA MISEQ,ADULT MALES  AGING BETWEEN 21 AND 65,251.0,SRR3889550,SRS1560541,HCV_GM__AMA_P5_R2,02/22/2015,PAIRED,"29.076360, 31.097000",STOOL,,,CAMP,,BENI-SUEF,V4,
